‘$VERU FDA Decision Coming On Oct 6’; Shares Move Higher

https://twitter.com/bio_clouseau/status/1567495687524286467

byBenzinga Newsdesk

September 7, 2022

1 minute read

$VERU adcom on 10/6 pic.twitter.com/bQrP3Ci1Xz

— M (@bio_clouseau) September 7, 2022

Jin Medical International Limited H1 Revenue $10.25M Vs $9.47M YoY

By Happy Mohamed

August 23, 4:26 PM

Financial and Operational Highlights for Six Months Ended March 31, 2023 Revenues were $10.25 million, representing an 8.3% increase from $9.47 million for the first six months

ZJYL

YETI Holdings Q2 EPS $0.63 Misses $0.68 Estimate, Sales $420.04M Miss $423.24M Estimate

By Bill Haddad

August 4, 6:05 AM

YETI Holdings (NYSE:YETI) reported quarterly earnings of $0.63 per share which missed the analyst consensus estimate of $0.68 by 7.35 percent. This is a 7.35 percent decrease over earnings of $0.68 per share from the

YETI

Merus Presents Preclinical Data Demonstrating Efficacy Of Zeno In Cancer Models With High NRG1 Expression At The AACR Annual Meeting 2024

By Benzinga Newsdesk

April 8, 12:03 PM

Merus N.V. (NASDAQ:MRUS) ("Merus", "the Company", "we", or "our"), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced

MRUS